Drug class in one race
CD4 receptor drugs for HIV
2 tracked CD4 receptor drugs in the HIV race. The class explanation lives on the CD4 receptor page; the full indication pipeline across every mechanism is on the HIV page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Ibalizumab vs Semzuvolimab